You are here

UCART123

Cellectis drops one of its 3 clinical-stage CAR-Ts

Fierce Biotech

Tue, 11/5/24 - 06:19 pm

FDA lifts hold on Cellectis’ CAR-T trial, adds go-slow caveat

Fierce Biotech

Tue, 11/7/17 - 09:38 am

clinical trials

Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T

Xconomy

Tue, 09/5/17 - 09:50 am

clinical trials

Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study

Endpoints

Sat, 08/19/17 - 10:29 am